1. 115 Erroneously normal active B12 level in a case of subacute combined degeneration of the cord. (23rd August 2021) Authors: Halliwell, Nicholas; Forsyth, Cecily; Taylor, Nicholas; Mangalasseril, Sarah; Sturm, Jonathan Journal: BMJ neurology open Issue: Volume 3(2021) Supplement 1 Page Start: A41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case‐based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis. Issue 3 (March 2017) Authors: Ho, P. Joy; Bajel, Ashish; Burbury, Kate; Dunlop, Lindsay; Durrant, Simon; Forsyth, Cecily; Perkins, Andrew C.; Ross, David M. Journal: Internal medicine journal Issue: Volume 47:Issue 3(2017) Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea. Issue 1 (2nd January 2017) Authors: Douglas, Genevieve; Harrison, Claire; Forsyth, Cecily; Bennett, Michael; Stevenson, William; Hounsell, John; Ratnasingam, Sumita; Ritchie, David; Ross, David M.; Grigg, Andrew Journal: Leukemia & lymphoma Issue: Volume 58:Issue 1(2017) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changing incidence of myeloproliferative neoplasms in Australia, 2003‐2014. Issue 4 (12th February 2019) Authors: Baade, Peter D.; Ross, David M.; Anderson, Lesley A.; Forsyth, Cecily; Fritschi, Lin Journal: American journal of hematology Issue: Volume 94:Issue 4(2019:Apr.) Page Start: E107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical characteristics of Australian treatment‐naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry. (28th December 2022) Authors: Nguyen, James; Wellard, Cameron; Chung, Eliza; Cheah, Chan Y.; Dickinson, Michael; Doo, Nicole Wong; Keane, Colm; Talaulikar, Dipti; Berkahn, Leanne; Morgan, Susan; Hamad, Nada; Cochrane, Tara; Johnston, Anna M.; Forsyth, Cecily; Opat, Stephen; Barraclough, Allison; Mutsando, Howard; Ratnasingam,... Journal: European journal of haematology Issue: Volume 110:Number 4(2023) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cutaneous multiple myeloma. (16th April 2020) Authors: Forsyth, Cecily; Lai, Sara; Jagger, Jacqueline Journal: British journal of haematology Issue: Volume 190:Number 2(2020) Page Start: 134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea. Issue 5 (May 2014) Authors: Verner, Emma; Forsyth, Cecily; Grigg, Andrew Journal: Leukemia & lymphoma Issue: Volume 55:Issue 5(2014:May) Page Start: 1139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Delayed‐onset heparin‐induced thrombocytopenia complicated by arterial and venous thromboses. Issue 1 (3rd January 2018) Authors: Balendran, Shalini; Harrison, Alexander; Morel‐Kopp, Marie‐Christine; Ward, Christopher; Forsyth, Cecily Journal: Internal medicine journal Issue: Volume 48:Issue 1(2018) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms. Issue 11 (8th April 2016) Authors: Malherbe, Jacques A J; Fuller, Kathryn A; Mirzai, Bob; Kavanagh, Simon; So, Chi-Chiu; Ip, Ho-Wan; Guo, Belinda B; Forsyth, Cecily; Howman, Rebecca; Erber, Wendy N Journal: Journal of clinical pathology Issue: Volume 69:Issue 11(2016) Page Start: 1017 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation. Issue 1 (2nd January 2020) Authors: Joshi, Maansi; Taper, John; Forsyth, Cecily; Rowlings, Philip; Campbell, Philip; Crispin, Philip; Harvey, Michael; Underhill, Craig; Bayley, Angela; Byth, Karen; Huang, Gillian; Hertzberg, Mark Journal: Leukemia & lymphoma Issue: Volume 61:Issue 1(2020) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗